Listed

Electromed, Inc.

ELMDNYSECIK 1488917HealthcareFiscal year ends Jun 30

Reports and events: 244 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Electromed, Inc., Reports and events
FiledFormWhat it isAccession number
2026-09-2916:17 ETDEF 14AProxy statementPeriod 2026-11-130001437749-26-031465
2026-08-2516:11 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-028915
2026-08-2516:11 ET10-KAnnual reportPeriod 2026-06-300001437749-26-028914
2026-05-1216:10 ET10-QQuarterly reportPeriod 2026-03-310001437749-26-016429
2026-05-1216:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-016422
2026-02-1016:11 ET10-QQuarterly reportPeriod 2025-12-310001437749-26-003635
2026-02-1016:11 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-003636
2025-12-1816:46 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001437749-25-038291
2025-11-1816:17 ET8-K5.07 Shareholder vote results0001437749-25-035598
2025-11-1216:11 ET10-QQuarterly reportPeriod 2025-09-300001437749-25-034445
2025-11-1216:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-25-034438
2025-09-3016:15 ETDEF 14AProxy statementPeriod 2025-11-140001437749-25-030113
2025-09-0909:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-25-028605
2025-08-2616:11 ET10-KAnnual reportPeriod 2025-06-300001437749-25-027761
2025-08-2616:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-25-027760
2025-05-1316:11 ET10-QQuarterly reportPeriod 2025-03-310001437749-25-016450
2025-05-1316:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-25-016436
2025-03-1009:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000897101-25-000125
2025-02-2420:15 ETSCHEDULE 13D/AOwnership report, active investor, amended0000921895-25-000593
2025-02-1116:10 ET10-QQuarterly reportPeriod 2024-12-310000897101-25-000089
2025-02-1116:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-25-000088
2024-11-2116:09 ETSC 13D/AOwnership report, active investor, amended0000897101-24-000592
2024-11-1816:31 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000897101-24-000581
2024-11-1216:10 ET10-QQuarterly reportPeriod 2024-09-300000897101-24-000563
2024-11-1216:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-24-000562
2024-10-0116:15 ETDEF 14AProxy statementPeriod 2024-11-150000897101-24-000487
2024-09-1108:55 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000897101-24-000443
2024-08-2716:30 ET10-KAnnual reportPeriod 2024-06-300000897101-24-000422
2024-08-2716:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-24-000421
2024-08-0716:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-24-000346
2024-05-0716:30 ET10-QQuarterly reportPeriod 2024-03-310000897101-24-000163
2024-05-0716:16 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-24-000162
2024-02-1316:10 ET10-QQuarterly reportPeriod 2023-12-310000897101-24-000070
2024-02-1316:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-24-000069
2023-12-1508:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000897101-23-000540
2023-11-1517:24 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-23-000503
2023-11-0716:30 ET10-QQuarterly reportPeriod 2023-09-300000897101-23-000477
2023-11-0716:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000897101-23-000476
2023-09-2616:08 ETDEF 14AProxy statementPeriod 2023-11-100000897101-23-000410
2023-08-2216:15 ET10-KAnnual reportPeriod 2023-06-300000897101-23-000380
2023-08-2216:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000897101-23-000379
2023-06-1516:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000897101-23-000248
2023-06-0508:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-23-000235
2023-05-0916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000897101-23-000193
2023-05-0916:06 ET10-QQuarterly reportPeriod 2023-03-310000897101-23-000192
2023-02-1416:33 ETSC 13D/AOwnership report, active investor, amended0000897101-23-000087
2023-02-1416:11 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000897101-23-000086
2023-02-1416:10 ET10-QQuarterly reportPeriod 2022-12-310000897101-23-000085
2022-11-1714:14 ET8-K5.07 Shareholder vote results0000897101-22-001004
2022-11-0816:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000897101-22-000946

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.